Top compounds associated with response to OR3A1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0053 0.9
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.0052 0.9
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0051 0.9
mRNA cimetidine CTRPv2 pan-cancer AAC -0.009 0.9
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0047 0.9
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.0048 0.9
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC -0.0058 0.9
mRNA RG-108 CTRPv2 pan-cancer AAC 0.0047 0.9
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.0094 0.9
mRNA BMS-195614 CTRPv2 pan-cancer AAC 0.0047 0.9
Download CSV